4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-009234
Chairman, President & CEO sold 162,777 shares at an average $84.63 ($13,775,792)
- Chairman, President & CEO acquired 111,886 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mahoney Michael F · Chairman, President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +56,211 | $17.26 | $970,202 | 1,679,198 | D |
| 2024-10-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +55,675 | $16.31 | $908,059 | 1,734,873 | D |
| 2024-10-07 | Sale : show line 3 in the form 10b5-1 | −80,692 | $84.31 | $6,803,360 | 1,654,181 | D |
| 2024-10-07 | Sale : show line 4 in the form 10b5-1 | −82,085 | $84.94 | $6,972,431 | 1,572,096 | D |
| Open-market sales · 162,777 sh · avg $84.63 · $13,775,792 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-07 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −56,211 | 224,846 | D |
| 2024-10-07 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −55,675 | 55,676 | D |
Loading xslF345X05/doc4.xml…